Establish Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment
Establish Comprehensive Quantitative Measurements of Laryngeal Sensorimotor Functions and Evaluating the Grade of Phonation and Swallowing Impairment
1 other identifier
observational
70
1 country
1
Brief Summary
Laryngeal motor and sensory nerve dysfunction may cause phonation and swallowing disturbance, which often happens after the treatment for laryngopharyngeal and esophageal cancer and may induce fatal complications such as aspiration pneumonia. By the conventional examinations, the tiny sensory or motor changes are hard to be detected before complete vocal paralysis. It is utmost important to establish a comprehensive quantitative method which is sensitive enough to evaluate the neuromuscular functions. The present project will evaluate the laryngeal nerve function by quantitative laryngeal electromyography, which was developed by the research team, and another novel examination technique, mucosal membrane sensation test. The comprehensive method is expected to grade the laryngeal nerve injuries quantitatively before the significant symptoms or complications and can also help to evaluate the treatment effect from medicine, rehabilitation or surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 16, 2014
CompletedFirst Posted
Study publicly available on registry
September 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2016
CompletedSeptember 18, 2014
February 1, 2014
2.1 years
September 16, 2014
September 16, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fiberoptic endoscopic evaluation of swallowing (FEES)
Swallowing evaluation
Baseline:Within 3-6 months after synptom occurs
Laryngo-pharyngeal mucosa sensation test
There were four probes of different diameters that similar to the Von Frey filament were prepared for the examination. The diameters were 0.07mm, 0.15mm.0.2 mm and 0.3 mm. The mono-filament nylon probe was placed and contact with the tip and arytenoid mucosa.
Baseline:Within 3-6 months after synptom occurs
Secondary Outcomes (5)
laryngeal electromyography
Baseline:Within 3-6 months after synptom occurs
laboratory voice analysis
Baseline:Within 3-6 months after synptom occurs
voice range profile
Baseline:Within 3-6 months after synptom occurs
Voice Handicap Index (VHI)
Baseline:Within 3-6 months after synptom occurs
Disease related life quality assessment: FACT-H&N, FACT-E
Baseline:Within 3-6 months after synptom occurs
Study Arms (1)
Larynx pharynx and Esophagus Ca with VCP
The cases of laryngopharyngeal and esophageal cancer with endoscopic characters of vocal fold motion impairment (paralysis or fixation)
Eligibility Criteria
Patients from a tertian referral medical center.
You may qualify if:
- Patients with laryngopharyngeal or esophageal cancer who have taken active therapy and are not neck tissue damage.
- Patients with clear conscious and stable mental status
You may not qualify if:
- Patients who cannot sit for longer than 30 minutes or received other vocal cord treatments before the selection
- Pregnant and breastfeeding women
- Patients with communication disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Taoyuan District, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tuan-Jen Fang, MD
Chang Gung Memorial Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 16, 2014
First Posted
September 18, 2014
Study Start
July 1, 2014
Primary Completion
August 1, 2016
Study Completion
November 1, 2016
Last Updated
September 18, 2014
Record last verified: 2014-02